review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Jane E. Freedman | Q125127316 |
P2093 | author name string | Lea M Beaulieu | |
P2860 | cites work | Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome | Q24306498 |
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo | Q28194375 | ||
Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation | Q28196450 | ||
Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis | Q82097175 | ||
Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors | Q28222522 | ||
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood | Q28294906 | ||
Decoding the patterns of self and nonself by the innate immune system | Q29618448 | ||
Role of blood platelets in infection and inflammation | Q33344923 | ||
Platelets express functional Toll-like receptor-4. | Q33366814 | ||
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo | Q33368585 | ||
Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway | Q33384817 | ||
Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release | Q33477430 | ||
Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. | Q33988923 | ||
Antimicrobial peptides from human platelets | Q34258124 | ||
Interaction of lipoteichoic acid of group A streptococci with human platelets | Q34407793 | ||
The role of Toll-like receptor 2 in microbial disease and immunity | Q35134715 | ||
Normal structure, function, and histology of the bone marrow | Q36635925 | ||
Platelet aggregation induced by serotype polysaccharides from Streptococcus mutans. | Q37427087 | ||
Expression of Toll-like receptors on human platelets | Q37866864 | ||
Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease? | Q37869092 | ||
Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock | Q39826933 | ||
Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. | Q40473187 | ||
Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity | Q40801728 | ||
Innate immunity: impact on the adaptive immune response | Q41353080 | ||
Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase | Q42137745 | ||
Pharmacological characterization of anaphylaxis-like shock responses induced in mice by mannan and lipopolysaccharide | Q43276426 | ||
Aggregation of human platelets by gingipain-R from Porphyromonas gingivalis cells and membrane vesicles. | Q43936812 | ||
A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation | Q44045919 | ||
Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets | Q44215892 | ||
Effects of tetanus toxin, Salmonella typhimurium porin, and bacterial lipopolysaccharide on platelet aggregation | Q44497103 | ||
Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. | Q45066041 | ||
Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase | Q46854879 | ||
Thrombocytes respond to lipopolysaccharide through Toll-like receptor-4, and MAP kinase and NF-kappaB pathways leading to expression of interleukin-6 and cyclooxygenase-2 with production of prostaglandin E2. | Q50068774 | ||
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood | Q58831626 | ||
Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets | Q60687230 | ||
Platelet activation by Protease I of Porphyromonas gingivalis W83 | Q70469219 | ||
Effects of endotoxemia on thrombopoiesis in men | Q77425094 | ||
Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets | Q77476698 | ||
Induction of platelet thrombi by bacteria and antibodies | Q78410425 | ||
Immediate effects of intravenous endotoxin on serotonin concentrations and blood platelets | Q79207419 | ||
Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9 | Q79443070 | ||
Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes | Q79819381 | ||
In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk | Q80134207 | ||
Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets | Q80716085 | ||
Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor | Q81443659 | ||
Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism | Q81472583 | ||
Evidence of Toll-like receptor molecules on human platelets | Q81479217 | ||
Toll-like receptors on platelets: the key for disseminated intravascular coagulation in sepsis? | Q81579388 | ||
Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria | Q81770492 | ||
P433 | issue | 3 | |
P921 | main subject | inflammation | Q101991 |
toll-like receptor | Q408004 | ||
P304 | page(s) | 205-209 | |
P577 | publication date | 2009-11-27 | |
P1433 | published in | Thrombosis Research | Q15758741 |
P1476 | title | The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes | |
P478 | volume | 125 |
Q28083403 | Are Platelets Cells? And if Yes, are They Immune Cells? |
Q38133641 | Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology? |
Q33401507 | Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections? |
Q36510868 | Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. |
Q51704486 | Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets. |
Q90282070 | Megakaryocytes contain extranuclear histones and may be a source of platelet-associated histones during sepsis |
Q36018314 | Micro-concentration Lipopolysaccharide as a Novel Stimulator of Megakaryocytopoiesis that Synergizes with IL-6 for Platelet Production |
Q36942040 | Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE-/- mice and activate platelets via TLR2. |
Q48302820 | Obesity and Altered Aspirin Pharmacology |
Q42326717 | Platelet Ca(2+) responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca(2+) stores |
Q91971794 | Platelet Inflammatory Response to Stress |
Q35213593 | Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection |
Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
Q92228726 | Platelets: Lone Rangers of Inflammatory Signaling in the Lung |
Q35536246 | Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studies |
Q35922965 | RETRACTED ARTICLE: HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms |
Q89511537 | Reduced miR-26b Expression in Megakaryocytes and Platelets Contributes to Elevated Level of Platelet Activation Status in Sepsis |
Q92959413 | Role of NF-κB in Platelet Function |
Q33437089 | Strains of Group B streptococci from septic patients induce platelet activation via Toll-like Receptor 2. |
Q47993062 | TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia. |
Q27004467 | The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors |
Q33401328 | The innateness of platelets |
Q35186543 | The role of platelets in the pathogenesis of viral hemorrhagic fevers |
Q89731964 | Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes |
Q47147432 | Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis. |
Q47285918 | Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8. |
Search more.